NCT04068194 2026-04-13Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary MalignanciesNational Cancer Institute (NCI)Phase 1/2 Active not recruiting103 enrolled